FDA Submits Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act

Summary

The Food and Drug Administration has submitted a proposed collection of information to the Office of Management and Budget for review and clearance, as required by the Paperwork Reduction Act of 1995, to establish a registration and product listing process for manufacturers of human blood and blood products and licensed devices.